Hyperfractionated radiotherapy followed by adjuvant chemotherapy for nasopharyngeal cancer: Report of seven cases

Japanese Journal of Clinical Oncology

Volumn 29, Issue 3, 1999, Pages 160-163

  Toita, Takafumi ^a   Ogawa, Kazuhiko ^a   Kamata, Minoru ^a   Kojya, Shizuo ^a   Itokazu, Tetsuo ^a   Kakinohana, Yasumasa ^a   Iraha, Shiro ^a   Yoshinaga, Masatomi ^a   Zukeran, Yuko ^a   Sawada, Satoshi ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Adjuvant chemotherapy; Nasopharyngeal neoplasms; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CF REGIMEN; CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NASOPHARYNX TUMOR; PILOT STUDY; RADIATION DOSE FRACTIONATION; RADIOTHERAPY; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PILOT PROJECTS; RADIOTHERAPY; TREATMENT OUTCOME;

EID: 17644428886     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.3.160     Document Type: Article

References (18)

1. Altum M, Fandi A, Dupuis O, Cvitkovic E, Krajina Z, Eschwege F. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys 1995;32:859-77.
2. Marks JE, Bedwinek JM, Lee F, Purdy JA, Perez CA. Dose-response analysis for nasopharynseal carcinoma. An historical perspective. Cancer 1952;50:1042-50.
3. Sanguineti G, Geara FB, Garden AS, Tucker SL, Kian Ang K, Morrison WH, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and resional control. Int J Radiat Oncol Biol Phys 1997;37:985-96.
4. Tannock I, Payne D, Cummings B, Hewitt K, Panzarella T and the Princess Margaret Hospital Head and Neck Cancer Group. Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy. J Clin Oncol 1987;5:629-34.
5. Toita T, Sueyama H, Takizawa Y, Kushi A, Ogawa K, Hara R, et al. Induction chemotherapy (cisplatin and 5-fluorouracil) and irradiation for nasopharygeal cancer. Nihon Ganchiryo gakkaishi 1994;29:1629-38.
6. Chan ATC, Teo PML, Leung TWT, Leung SF, Lee WY, Yeo W, et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharynseal carcinoma. Int J Radiat Oncol Biol Phys 1995;33:569-77.
7. International Nasopharynx Cancer Study Group. VUMCA I trial. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (= N2, M0) Undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys 1996;35:463-9.
8. Garden AS, Lippman SM, Morrison WH, Glisson BS, Kian Ang K, Geara F, et al. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography. Int J Radiat Oncol Biol Phys 1996;36:1005-12.
9. Al-Sarraf M, LeBlanc M, Giri PGS, Fu KK, Cooper J, Vuong T, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099. J Clin Oncol 1998;16:1310-7.
10. Perez CA, Brady LW. Overview. In: Perez CA, Brady LW, editors. Principles and Practice of Radiation Oncology, 2nd ed. Philadelphia: JB Lippincott 1992:1-63.
11. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48. Geneva: World Health Organization 1979.
12. Wang CC. Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results. Cancer 1989;63:2461-7.
13. Teo PML, Kwan WH, Leung SF, Leung WT, Chan A, Choi P, et al. Early tumour response and treatment toxicity after hyperfractionated radiotherapy in nasopharyngeal carcinoma. Br J Radiol 1996;69:241-8.
14. Cox JD, Pajak TF, Marcial VA, Coia L, Mohiuddin M, Fu KK, et al. ASTRO plenary. Interfraction interval is a major determinant of late effects, with hyperfractionated radiation therapy of carcinomas of upper respiratory and digestive tracts: results from Radiation Therapy Oncology Group protocol 8313. Int J Radiat Oncol Biol Phys 1991;20:1191-5.
15. Perez CA. Nasopharynx. In: Perez CA, Brady LW, editors. Principles and Practice of Radiation Oncology, 3rd ed. Philadelphia: JB Lippincott 1998:897-939.
16. Cmelak AJ, Cox RS, Adler JR, Fee WE, Goffinet DR. Radiosurgery for skull base malignancies and nasopharynaeal carcinoma. Int J Radiat Oncol Biol Phys 1997;37:997-1003.
17. Rossi A, Molinari R, Boracchi P, Del Vecchio M, Marubini E, Nava M, et al. Adjuvant chemotherapy with vincristin, cyclophosphamide and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988;6:1401-10.
18. Tsujii H, Kamada T, Tsuji H, Takamura A, Matsuoka Y, Usubuchi H, et al. Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy. Cancer 1989;63:1668-72.